Mannkind (MNKD) Gross Margin (2016 - 2026)
Mannkind (MNKD) reported Gross Margin of 91.67% for Q1 2026, down 352.0% year-over-year from 36.38% in Q1 2025, and up 4.7% on a QoQ basis from 87.56% in Q4 2025.
Mannkind (MNKD) has 11 years of Gross Margin data on file, last reported at 91.67% in Q1 2026.
- Quarterly Gross Margin fell 352.0% year-over-year to 91.67% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 91.53% (down 263.0% YoY) and the FY2025 annual result came in at 92.32%, down 158.0% from the prior year.
- Gross Margin climbed to 91.67% in Q1 2026 per MNKD's latest filing, from 87.56% in the prior quarter.
- Across five years, Gross Margin topped out at 172.48% in Q4 2022 and bottomed at 1439.0% in Q2 2022.
- The 5-year median for Gross Margin is 92.26% (2024), against an average of 1.71%.
- The widest annual swing landed in 2022, when Gross Margin slumped 152005 bps; it then surged 151020 bps in 2023.
- Tracing MNKD's Gross Margin over 5 years: stood at 172.48% in 2022, then declined by 22 bps to 134.01% in 2023, then slumped by 30 bps to 93.74% in 2024, then declined by 7 bps to 87.56% in 2025, then gained by 5 bps to 91.67% in 2026.
- Per Business Quant, the three latest MNKD Gross Margin figures stand at 91.67% (Q1 2026), 87.56% (Q4 2025), and 94.52% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 79.04% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 86.85% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 91.79% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 82.22% |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 91.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.67% |
| Dec 31, 2025 | 87.56% |
| Sep 30, 2025 | 94.52% |
| Jun 30, 2025 | 93.98% |
| Mar 31, 2025 | 95.19% |
| Dec 31, 2024 | 93.74% |
| Sep 30, 2024 | 95.44% |
| Jun 30, 2024 | 92.26% |
| Mar 31, 2024 | 94.24% |
| Dec 31, 2023 | 134.01% |
| Sep 30, 2023 | 73.78% |
| Jun 30, 2023 | 71.20% |
| Mar 31, 2023 | 67.24% |
| Dec 31, 2022 | 172.48% |
| Sep 30, 2022 | 58.75% |
| Jun 30, 2022 | -1,439.00% |
| Mar 31, 2022 | -6.14% |
| Dec 31, 2021 | -163.60% |
| Sep 30, 2021 | 82.84% |
| Jun 30, 2021 | 81.05% |
| Mar 31, 2021 | 75.25% |
| Dec 31, 2020 | 80.20% |
| Sep 30, 2020 | 76.61% |
| Jun 30, 2020 | -1,738.50% |
| Mar 31, 2020 | 74.35% |
| Dec 31, 2019 | 71.04% |
| Sep 30, 2019 | -914.14% |
| Jun 30, 2019 | -2,063.50% |
| Mar 31, 2019 | 76.96% |
| Dec 31, 2018 | 68.90% |
| Sep 30, 2018 | -18.66% |
| Jun 30, 2018 | -30.88% |
| Mar 31, 2018 | -15.67% |
| Dec 31, 2017 | -10.77% |
| Sep 30, 2017 | -123.94% |
| Jun 30, 2017 | -135.14% |
| Mar 31, 2017 | 15.32% |
| Dec 31, 2016 | 66.07% |
| Sep 30, 2016 | 97.29% |